Hospital Clinico Lozano Blesa   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Zaragoza Spain (1974)

Organization Overview

First Clinical Trial
2007
NCT01361191
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Digestive disease service of Hospital Clinico Lozano Blesa | Hospital Clínico Lozano Blesa, Zaragoza | Hospital Clínico Universitario Lozano Blesa | HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA, ZARAGOZA | Hospital Lozano Blesa | Lozano Blesa Clinic | Medical Oncology Service. Hospital Clinico Lozano Blesa. Zaragoza. Spain

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Barrett Esophagus (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cholangiocarcinoma (Phase 4)

Colorectal Neoplasms (Phase 3)

Klatskin Tumor (Phase 4)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Urticaria (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 23